Zymeworks Inc. (ZYME) Q1 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-05-09 00:21:17 ET
Zymeworks Inc. (ZYME) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT
Company Participants
Shrinal Inamdar - VP of Investor Relations
Kenneth Galbraith - Chairman of the Board, CEO & President
Kristin Stafford - Executive VP & CFO
Paul Moore - Chief Scientific Officer
Sabeen Mekan - SVP & Chief Medical Officer
Adam Schayowitz - Executive VP and Head of Research & Development
...
Read the full article on Seeking Alpha
For further details see:
Zymeworks Inc. (ZYME) Q1 2026 Earnings Call Transcript
Zymeworks Inc.
NASDAQ: ZYME
ZYME Trading
-2.67% G/L:
$24.45 Last:
155,148 Volume:
$25.04 Open:
ZYME Latest News
May 14, 2026 04:05:00 pm
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
May 07, 2026 04:05:00 pm
Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results
ZYME Stock Data
$1,697,666,774
73,882,368
0.51%
61
N/A
Biotechnology & Life Sciences
Healthcare
CA
Middletown
